{
  "retracted": false,
  "timestamp": 1533081600000,
  "updates": [
    {
      "timestamp": 1585522815479,
      "identifier": {
        "doi": "10.1016/j.amjcard.2018.01.010"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.amjcard.2017.02.020"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)’ The American Journal of Cardiology 119 (2017) 1576–1583"
}
